229 related articles for article (PubMed ID: 21632869)
21. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
[TBL] [Abstract][Full Text] [Related]
22. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Sensken SC; Bode C; Gräler MH
J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
[TBL] [Abstract][Full Text] [Related]
24. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
Natarajan V; Dudek SM; Jacobson JR; Moreno-Vinasco L; Huang LS; Abassi T; Mathew B; Zhao Y; Wang L; Bittman R; Weichselbaum R; Berdyshev E; Garcia JG
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):6-17. PubMed ID: 23449739
[TBL] [Abstract][Full Text] [Related]
28. Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice.
Blé FX; Cannet C; Zurbruegg S; Gérard C; Frossard N; Beckmann N; Trifilieff A
Br J Pharmacol; 2009 Nov; 158(5):1295-301. PubMed ID: 19785648
[TBL] [Abstract][Full Text] [Related]
29. Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.
Obinata H; Gutkind S; Stitham J; Okuno T; Yokomizo T; Hwa J; Hla T
J Lipid Res; 2014 Dec; 55(12):2665-75. PubMed ID: 25293589
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
Clemens JJ; Davis MD; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
[TBL] [Abstract][Full Text] [Related]
32. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine 1-phosphate chemical biology.
Lynch KR; Macdonald TL
Biochim Biophys Acta; 2008 Sep; 1781(9):508-12. PubMed ID: 18638568
[TBL] [Abstract][Full Text] [Related]
34. FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction.
Sobel K; Monnier L; Menyhart K; Bolinger M; Studer R; Nayler O; Gatfield J
Mol Pharmacol; 2015 Jun; 87(6):916-27. PubMed ID: 25762025
[TBL] [Abstract][Full Text] [Related]
35. Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls.
Bolli MH; Lescop C; Nayler O
Curr Top Med Chem; 2011; 11(6):726-57. PubMed ID: 21261590
[TBL] [Abstract][Full Text] [Related]
36. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.
Allende ML; Sasaki T; Kawai H; Olivera A; Mi Y; van Echten-Deckert G; Hajdu R; Rosenbach M; Keohane CA; Mandala S; Spiegel S; Proia RL
J Biol Chem; 2004 Dec; 279(50):52487-92. PubMed ID: 15459201
[TBL] [Abstract][Full Text] [Related]
37. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools.
Salomone S; Potts EM; Tyndall S; Ip PC; Chun J; Brinkmann V; Waeber C
Br J Pharmacol; 2008 Jan; 153(1):140-7. PubMed ID: 18026125
[TBL] [Abstract][Full Text] [Related]
38. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.
Mullershausen F; Zecri F; Cetin C; Billich A; Guerini D; Seuwen K
Nat Chem Biol; 2009 Jun; 5(6):428-34. PubMed ID: 19430484
[TBL] [Abstract][Full Text] [Related]
39. A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis.
Quancard J; Bollbuck B; Janser P; Angst D; Berst F; Buehlmayer P; Streiff M; Beerli C; Brinkmann V; Guerini D; Smith PA; Seabrook TJ; Traebert M; Seuwen K; Hersperger R; Bruns C; Bassilana F; Bigaud M
Chem Biol; 2012 Sep; 19(9):1142-51. PubMed ID: 22999882
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
